Physicians and leaders from across The US Oncology Network participated in speaker panels and presented on various topics at the 2018 Communication Oncology Conference in National Harbor, MD on April 12 – 13.
Joyce O’Shaughnessy, MD of Texas Oncology weighed in on the CDK4/CDK6 Protein Coding in Breast Cancer session, Houston Holmes, MD, MBA, FACP of Texas Oncology presented on CAR-T in Community Oncology Practice, and Robert M. Rifkin, MD, FACP, medical director, Biosimilars, The US Oncology Network presented on The New World of Biosimilars: From Clinical Use to Reimbursement.
In addition, Ben Jones, vice president of Government Relations and Public Policy, The US Oncology Network, joined the Washington, D.C. Update: The Latest Legislative Issues Impacting Cancer Care & Your Practice panel discussion during the general session and Debra Patt, MD, MPH, MBA, vice president, Texas Oncology, participated in the Community Oncology 101: Key Issues Impacting Patients and Practices panel discussion.